Guidelines for treating iron overload in myelodysplastic syndromes: A Taiwan consensus statement

Bor Sheng Ko, Cheng Shyong Chang, Ming Chih Chang, Tsai Yun Chen, Tzeon Jye Chiou, Chang Fang Chiu, Wen Li Huang, Woei Yau Kao, Yii Jenq Lan, Shen Fung Lin, Tran Der Tan, Jih Luh Tang, Cheng Hwai Tzeng, Po Nan Wang, Su Pen Yet, Hwei Fang Tien

研究成果: Review article同行評審

6 引文 斯高帕斯(Scopus)

摘要

Iron overload is common in myelodysplastic syndrome (MDS) patients, and an accumulation of evidence shows that iron chelation may have benefits in these patients. However, discussion and consensus about iron chelation therapy (ICT) for MDS patients is lacking in Taiwan and other Southeast Asian countries. An Expert Panel in Taiwan was organized in 2011 to develop iron overload guidelines and provide a uniform reference for physicians treating MDS patients with iron overload, with specific regard to when to initiate ICT, in which patients, and the clinical and scientific rationale behind its use.

原文English
頁(從 - 到)7-15
頁數9
期刊International Journal of Hematology
100
發行號1
DOIs
出版狀態Published - 2014 七月

All Science Journal Classification (ASJC) codes

  • 血液學

指紋

深入研究「Guidelines for treating iron overload in myelodysplastic syndromes: A Taiwan consensus statement」主題。共同形成了獨特的指紋。

引用此